Common Stock, Shares, Outstanding of Oncology Institute, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Oncology Institute, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Oncology Institute, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 98,863,144, a 31% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Oncology Institute, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 98,863,144 +23,126,032 +31% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 97,569,737 +22,010,662 +29% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 93,279,822 +17,789,333 +24% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 88,928,026 +14,615,106 +20% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 75,737,112 +1,591,861 +2.1% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 75,559,075 +1,830,948 +2.5% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 75,490,489 +2,535,401 +3.5% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 74,312,920 +558,311 +0.76% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 74,145,251 +879,630 +1.2% 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q3 2023 73,728,127 +1,386,440 +1.9% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 72,955,088 +974,216 +1.4% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 73,754,609 +478,379 +0.65% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 73,265,621 +16,579 +0.02% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 72,341,687 +49,341,687 +215% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 71,980,872 +48,980,872 +213% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 73,276,230 +50,276,230 +219% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 73,249,042 +50,249,042 +218% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 23,000,000 +17,250,000 +300% 30 Sep 2021 10-Q/A 14 Dec 2021 2021 Q3
Q2 2021 23,000,000 +17,250,000 +300% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 23,000,000 +17,250,000 +300% 31 Mar 2021 10-Q 28 May 2021 2021 Q1
Q4 2020 23,000,000 +17,250,000 +300% 31 Dec 2020 10-Q/A 14 Dec 2021 2021 Q3
Q3 2020 5,750,000 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 5,750,000 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 5,750,000 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 5,750,000 31 Dec 2019 10-K/A 14 Dec 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.